CoChat

Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH–JAPAN study

Open access
Hirata, Aya, Sugiyama, Daisuke, Watanabe, Makoto, Tamakoshi, Akiko, Iso, Hiroyasu, Kotani, Kazuhiko, Kiyama, Masahiko, Yamada, Michiko, Ishikawa, Shizukiyo, Murakami, Yoshitaka, Miura, Katsuyuki, Ueshima, Hirotsugu, Okamura, Tomonori, Ueshima, Hirotsugu, Okamura, Tomonori, Ueshima, Hirotsugu, Imai, Yutaka, Ohkubo, Takayoshi, Irie, Fujiko, Iso, Hiroyasu, Kitamura, Akihiko, Ninomiya, Toshiharu, Kiyohara, Yutaka, Miura, Katsuyuki, Murakami, Yoshitaka, Nakagawa, Hideaki, Nakayama, Takeo, Okayama, Akira, Sairenchi, Toshimi, Saitoh, Shigeyuki, Sakata, Kiyomi, Tamakoshi, Akiko, Tsuji, Ichiro, Yamada, Michiko, Kiyama, Masahiko, Miyamoto, Yoshihiro, Ishikawa, Shizukiyo, Yatsuya, Hiroshi, Okamura, Tomonori · 2018 · Journal of Clinical Lipidology
Cited by 148

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

BACKGROUND The effect of very high or extremely high levels of high-density lipoprotein cholesterol (HDL-C) on cardiovascular disease (CVD) is not well described. Although a few recent studies have reported the adverse effects of extremely high levels of HDL-C on CVD events, these did not show a statistically significant association between extremely high levels of HDL-C and cause-specific CVD mortality. In addition, Asian populations have not been studied. OBJECTIVE We examine the impact of extremely high levels of HDL-C on cause-specific CVD mortality using pooled data of Japanese cohort studies. METHODS We performed a large-scale pooled analysis of 9 Japanese cohorts including 43,407 participants aged 40-89 years, dividing the participants into 5 groups by HDL-C levels, including extremely high levels of HDL-C ≥2.33 mmol/L (≥90 mg/dL). We estimated the adjusted hazard ratio of each HDL-C category for all-cause death and cause-specific deaths compared with HDL-C 1.04-1.55 mmol/L (40-59 mg/dL) using a cohort-stratified Cox proportional hazards model. RESULTS During a 12.1-year follow-up, 4995 all-cause deaths and 1280 deaths due to overall CVD were identified. Extremely high levels of HDL-C were significantly associated with increased risk of atherosclerotic CVD mortality (hazard ratio = 2.37, 95% confidence interval: 1.37-4.09 for total) and increased risk for coronary heart disease and ischemic stroke. In addition, the risk for extremely high HDL-C was more evident among current drinkers. CONCLUSION We showed extremely high levels of HDL-C had an adverse effect on atherosclerotic CVD mortality in a pooled analysis of Japanese cohorts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacl.2018.01.014

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 148

Metadata

Authors
Hirata, A., Sugiyama, D., Watanabe, M., Tamakoshi, A., Iso, H., Kotani, K., Kiyama, M., Yamada, M., Ishikawa, S., Murakami, Y., Miura, K., Ueshima, H., Okamura, T., Ueshima, H., Okamura, T., Ueshima, H., Imai, Y., Ohkubo, T., Irie, F., Iso, H., Kitamura, A., Ninomiya, T., Kiyohara, Y., Miura, K., Murakami, Y., Nakagawa, H., Nakayama, T., Okayama, A., Sairenchi, T., Saitoh, S., Sakata, K., Tamakoshi, A., Tsuji, I., Yamada, M., Kiyama, M., Miyamoto, Y., Ishikawa, S., Yatsuya, H., & Okamura, T.
Venue
Journal of Clinical Lipidology
Publisher
Elsevier BV
Published
2018-05
Volume
12
Issue
3
Pages
674-684.e5
ISSN
  • 1876-4789 (ISSN-L)
  • 1933-2874
OpenAlex
W2786334390
Cited by
148
References
15
FWCI
14.61
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.